NCT04536831 is a Phase 4 clinical trial of Vitamin D in Critically Ill, sponsored by Dr Mustahsin Khalil.

Who is sponsoring NCT04536831?

NCT04536831 is sponsored by Dr Mustahsin Khalil.

What drugs are being tested in NCT04536831?

Interventions in NCT04536831: Vitamin D, Normal saline.

What condition does NCT04536831 study?

NCT04536831 studies Critically Ill.

Is NCT04536831 still recruiting?

NCT04536831 is currently completed. Last updated 3 September 2020.

Last reviewed 2020-09-03 · How we verify

NCT04536831

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Association of Vitamin D Supplementation With the Outcome in Critically Ill Children

Completed Phase 4 Last updated 3 September 2020

What this trial tests

Phase 4 trial testing Vitamin D in Critically Ill in 96 participants. Completed in 25 February 2020.

Timeline

29 August 2019

Primary endpoint
25 February 2020

25 February 2020

Quick facts

Lead sponsor	Dr Mustahsin Khalil
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	health services research
Enrollment	96
Start date	29 August 2019
Primary completion	25 February 2020
Estimated completion	25 February 2020
Sites	1 location across Pakistan

Drugs / interventions tested

Vitamin D
Normal saline

Conditions studied

Critically Ill — all drugs for Critically Ill →

Sponsor

Dr Mustahsin Khalil

Who can join

Adults 6 Months to 10, any sex, with Critically Ill. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vitamin D deficiency is highly prevalent in critically ill adult and pediatric population that causes multiple adverse health outcomes including higher illness severity score, increased morbidity and mortality, multiple organ dysfunction, longer duration of Mechanical ventilation, longer duration of Oxygen therapy and increased length of stay (LOS) in PICU and hospital. Vitamin D deficiency is a modifiable risk factor that can be corrected with high dose of vitamin D supplementation to improve the clinical outcome. This study is designed to determine whether random vitamin D supplementation within dose limits improves clinical outcomes in critically ill children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Vitamin D

Trials testing the same drug.

NCT07366086 — Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta · Phase 3 · recruiting
NCT07458815 — Vitamin D for Acute Intracerebral Hemorrhage · NA · not yet recruiting
NCT07491965 — Association Between Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency . · not yet recruiting
NCT07400757 — Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease · NA · not yet recruiting
NCT07293910 — Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Py · Phase 2 · recruiting

Other recruiting trials for Critically Ill

Currently open trials in the same condition.

NCT07222007 — Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients · recruiting
NCT07143695 — Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion · NA · recruiting
NCT06473844 — Efficacy of SGLT2 Inhibitors in Adults With Sepsis · NA · recruiting
NCT05055830 — Opportunistic PK/PD Trial in Critically Ill Children (OPTIC) · recruiting
NCT05112328 — The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04536831 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr Mustahsin Khalil
Last refreshed: 3 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04536831.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing